Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)
NCT ID: NCT02088801
Last Updated: 2015-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
480 participants
INTERVENTIONAL
2014-02-28
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study consists of 4 arms. Each arm includes 120 patients, sums up to a total of 480 patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Video Laryngoscopes in Difficult Airway
NCT01692535
Comparison Study in Adult Surgical Patients of 5 Airway Devices
NCT00602979
Videolaryngoscopic Intubation Using Macintosh vs.Hyperangulated Blades in Patients With Expected Difficult Intubation
NCT05522049
Comparison of Two Novel Indirect Laryngoscopes to the Macintosh Laryngoscope in Patients With Cervical Spine Immobilization.
NCT01032460
Role of Airtraq Mobile to Improve Intubation Conditions With Airtraq
NCT02510924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Airtraq, blade without channel for tracheal tube
intubation
Airtraq, blade without channel for tracheal tube intubation
Intubation
KingVision , blade without channel for tracheal tube
intubation
KingVision , blade without channel for tracheal tube intubation
A.P. Advance, blade without channel for tracheal tube
intubation
A.P. Advance, blade without channel for tracheal tube intubation
Macintosh
intubation
Macintosh
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Airtraq, blade without channel for tracheal tube intubation
Intubation
KingVision , blade without channel for tracheal tube intubation
A.P. Advance, blade without channel for tracheal tube intubation
Macintosh
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>18 years old
* ASA I-III
Exclusion Criteria
* risk of pulmonary aspiration
* refusing to participate
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lorenz Theiler
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Greif, MD MME FERC
Role: STUDY_CHAIR
Insel Gruppe AG, University Hospital Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bern University Hospital and University of Bern
Bern, Canton of Bern, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SWIVIT II
Identifier Type: -
Identifier Source: secondary_id
106/12_2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.